Freshpet Reports Strong 2025 Financials, Exceeds $1.1B Sales, Posts Significant Net Income & Q1 2026 Equity Sale Gain
FRPT sits 68% above its 52-week low of $46.76 on elevated volume (2.0× avg).
Summary
Freshpet reported strong 2025 financial results with over $1.1 billion in net sales and a significant increase in net income, boosted by a tax valuation allowance release and a substantial post-year-end equity investment sale.
Key Events · Earnings and Guidance · FRPT
-
Strong 2025 Financial Performance
Net sales increased 13.0% to $1,102.0 million for the year ended December 31, 2025, surpassing $1 billion. Net income significantly rose to $139.1 million from $46.9 million in the prior year, and Adjusted EBITDA grew to $195.7 million (17.8% margin) from $161.8 million (16.6% margin).
-
Significant Income Tax Benefit
The company recognized a deferred income tax benefit of $68.8 million in 2025 due to the release of a majority of the valuation allowance against its deferred tax assets, reflecting sustained profitability and expected future taxable income.
-
Material Equity Investment Sale Post-Year-End
On January 16, 2026, Freshpet sold its non-controlling interest in a privately held company for $95.459 million in cash, expecting to recognize a pre-tax gain of approximately $62.013 million in Q1 2026. This significantly boosts future liquidity and earnings.
-
Continued Manufacturing Expansion
Freshpet continues to expand its manufacturing capacity, with Phase 2 commissioning of Freshpet Kitchens Ennis initiated in 2024 and Phase 3 planned for completion over the next several years. Capital expenditures for 2025 were $148.2 million, with $150.0 million projected for 2026.
Analysis · FRPT · Manufacturing
Freshpet's 2025 annual report reveals robust financial performance, with net sales surpassing $1.1 billion and a substantial increase in net income, largely driven by the release of a significant deferred tax asset valuation allowance. This indicates improved profitability and future tax efficiency. Additionally, the company disclosed a material subsequent event: the sale of a non-controlling equity interest in January 2026, which will result in a considerable cash inflow and pre-tax gain in the first quarter of 2026, further strengthening its financial position and liquidity. The company continues to execute its growth strategy, including manufacturing capacity expansion, while also improving capital efficiency.
At the time of this filing, FRPT was trading at $78.58 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $3.8B. The 52-week trading range was $46.76 to $111.62. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.